Voices
Tom Powles
Tom Powles/X

Tom Powles: Demonstrating the Rapid Advances in Drug Discovery from China at the 15th Shanghai GU Cancer Conference

Tom Powles, Head of Solid Tumor Research at Barts Cancer Institute, shared a post on X:

“15th Shanghai GU cancer conference demonstrates the rapid advances in drugs discovery from China, especially in ADCs and bispecifics.

Disitimab/Toripalimab is only one of a number of randomized trials including Nectin4/Topo1 and HER1+3/Topo1 ADCs.”

Tom Powles: Demonstrating the Rapid Advances in Drug Discovery from China at the 15th Shanghai GU Cancer Conference

More posts about GU cancer.

15th Shanghai GU cancer conference ADCs cancer GU cancer OncoDaily Oncology Tom Powles